The Conversation (0)
Pivot Pharmaceuticals announced it was added to the CSE25 Index, a composite of the 25 largest companies, as measured by market capitalization, listed on the CSE.
Pivot Pharmaceuticals (CSE:PVOT; OTCQB:PVOTF) announced it was added to the CSE25 Index, a composite of the 25 largest companies, as measured by market capitalization, listed on the Canadian Securities Exchange (CSE).
As quoted in the press release:
In addition, the Company is also a constituent of the CSE Composite Index.
“With an impressive pipeline of bio-cannabis products, a strong intellectual property portfolio of formulation and delivery technologies, and the expected addition of ACMPR licensed Agro-Biotech, we are proud to be recognized as leaders on the Canadian Securities Exchange through our inclusion in the CSE25 Index,” said Dr. Patrick Frankham, Chief Executive Officer of Pivot Pharmaceuticals.
Source: www.newswire.ca
